Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Most Promising Therapies in Interventional Cardiology.
Kerneis M, Nafee T, Yee MK, Kazmi HA, Datta S, Zeitouni M, Afzal MK, Jafarizade M, Walia SS, Qamar I, Pitliya A, Kalayci A, Al Khalfan F, Gibson CM. Kerneis M, et al. Among authors: nafee t. Curr Cardiol Rep. 2019 Mar 13;21(4):26. doi: 10.1007/s11886-019-1108-x. Curr Cardiol Rep. 2019. PMID: 30868280 Review.
Silent Myocardial Infarction: Listen to the Evidence.
Gibson CM, Nafee T, Kerneis M. Gibson CM, et al. Among authors: nafee t. J Am Coll Cardiol. 2018 Jan 2;71(1):9-11. doi: 10.1016/j.jacc.2017.10.069. J Am Coll Cardiol. 2018. PMID: 29301632 Free article. No abstract available.
Anticoagulation in Acute Coronary Syndrome-State of the Art.
Zeitouni M, Kerneis M, Nafee T, Collet JP, Silvain J, Montalescot G. Zeitouni M, et al. Among authors: nafee t. Prog Cardiovasc Dis. 2018 Jan-Feb;60(4-5):508-513. doi: 10.1016/j.pcad.2018.01.004. Epub 2018 Jan 13. Prog Cardiovasc Dis. 2018. PMID: 29339166 Review.
Effect of Procedure and Coronary Lesion Characteristics on Clinical Outcomes Among Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention: Insights From the PIONEER AF-PCI Trial.
Kerneis M, Gibson CM, Chi G, Mehran R, AlKhalfan F, Talib U, Pahlavani S, Mir M, Bode C, Halperin JL, Nafee T, Peterson ED, Verheugt FWA, Wildgoose P, van Eickels M, Lip GYH, Fox KAA, Cohen M. Kerneis M, et al. Among authors: nafee t. JACC Cardiovasc Interv. 2018 Apr 9;11(7):626-634. doi: 10.1016/j.jcin.2017.11.009. Epub 2018 Mar 14. JACC Cardiovasc Interv. 2018. PMID: 29550085 Free article. Clinical Trial.
Betrixaban for first-line venous thromboembolism prevention in acute medically ill patients with risk factors for venous thromboembolism.
Nafee T, Gibson CM, Yee MK, Alkhalfan F, Chi G, Travis R, Mir M, Kalayci A, Jafarizade M, Ganti A, Kazmi SH, Ghaffarpasand E, Pitliya A, Datta S, Sharfaei S, Alihashemi M, Elsaiey A, Qamar I, Jahansouz M, Talib U, Kahe F, Habibi S, Abdelwahed M, Tariq F, Kaur M, Younes A, Walia SS, Singh A, Dildar SM, Afzal MK, Kerneis M. Nafee T, et al. Expert Rev Cardiovasc Ther. 2018 Nov;16(11):845-855. doi: 10.1080/14779072.2018.1534068. Epub 2018 Oct 15. Expert Rev Cardiovasc Ther. 2018. PMID: 30296387 Review.
36 results